Browsing Tag
NSE: AARTIDRUGS
1 post
Aarti Drugs (NSE: AARTIDRUGS) profit climbs 29% in Q2 FY26 as export-led growth drives margin gains
Aarti Drugs posts 29% YoY profit growth in Q2 FY26 on rising exports and cost discipline. See how backward integration is boosting its margin outlook.